I’ve written about unusual deal terms before (here and here), but Bruce Booth’s awesome blog Life Sci VC just introduced me to a great new report on typical life science deal terms. While the big headline is that 83% of life science deals include earn-outs, I was surprised to learn that the average amount of equity invested in medical device companies prior to exit was $60M (median $44M). Senior medical device startup execs should definitely read Booth’s article and download the full report.
Read Booth’s post here.
Download the study here.
Read the press release here.
Press coverage on PE Hub here.
Related articles
- Study Sheds Light on Real Life Science Returns (pehub.com)
Jay Caplan on Medical Devices 